News

Understanding Capital Power's Conversion Privilege for Preferred Shares

Understanding Capital Power's Conversion Privilege for Preferred Shares

Capital Power Announces Series 1 Shares Conversion Details

Capital Power Corporation (TSX: CPX) has disclosed essential information for shareholders regarding the Cumulative Rate Reset Preference Shares, Series 1 (Series 1 Shares). This announcement highlights the conversion privilege and the relevant dividend rates applicable to these shares.

Timing and Process for Conversion

Starting from the designated date, registered shareholders will have the opportunity to convert their Series 1 Shares into an equal number of Cumulative Floating Rate Preference Shares, Series 2 (Series 2 Shares). This conversion period will run until late December, providing ample time for shareholders to make their decisions.

What Happens if No Election Notice is Received?

If no Election Notice is submitted within the specified period, the shareholders will be automatically considered to have retained their Series 1 Shares, unless an Automatic Conversion occurs based on specific criteria.

Future Conversions

Shareholders will not only have this chance but will also be eligible to convert shares every five years thereafter as long as the shares remain issued and outstanding. This ensures ongoing flexibility for investors eager to navigate market changes.

Dividend Rates: What to Expect

On the established date, the company set the fixed annual dividend for the Series 1 Shares, ensuring a consistent return for investors for the next five years. Meanwhile, the Series 2 Shares will have a floating dividend rate, which will be adjusted quarterly, starting from the first quarter of 2026.

Understanding Dividend Rates

With an annual fixed dividend rate for the Series 1 Shares established at 4.95800%, investors can view this as a steady income. Conversely, Series 2 Shares will see their quarterly floating rate reset, contributing to a more dynamic investment potential.

Current Status of Series 1 Shares

The Series 1 Shares exist in a unique format, issued only in “book entry” form, meaning that the registered holder is a clearing service. Beneficial holders must coordinate with their brokers to exercise their rights regarding these shares. As of now, a significant number of Series 1 Shares remains outstanding, which may influence conversion decisions.

Automatic Conversion Scenario

Should conditions arise that fewer than 1,000,000 Series 1 Shares would be remaining, an Automatic Conversion will occur, switching remaining Series 1 Shares over to Series 2 Shares. This ensures that the structure of capital is maintained and allows for a more stable operation within the market.

Listing and Trading of Series 2 Shares

The Toronto Stock Exchange (TSX) has provisionally approved the listing of Series 2 Shares upon successful conversion, with the listing under the symbol CPX.PR.B. This move showcases Capital Power’s commitment to adhere to market standards and its capacity for seamless transitions in shareholding.

Benefits of Investing in Capital Power

Investing in Capital Power means entering a growth-oriented segment of the energy market. The company has established a solid foundation across North America with diverse power generation facilities that prioritize sustainable practices. This strategy aligns with upcoming energy demands and promotes lower-carbon solutions for future generations.

Connecting with Capital Power

For shareholders and interested parties seeking detailed information about investment opportunities, Capital Power encourages reaching out directly through their dedicated channels. Their team stands ready to assist investors with any questions they may have regarding shares and associated programs.

Contact Information

For further queries, investors can connect with the Investor and Media Relations team. Media relations are spearheaded by Katherine Perron, who can be reached at (780) 392-5335 or via email. Additionally, inquiries regarding investments can be directed to Noreen Farrell at (403) 461-5236 or through her email.

Frequently Asked Questions

What is the conversion privilege for Capital Power's Series 1 Shares?

The conversion privilege allows shareholders to convert Series 1 Shares into Series 2 Shares during specific election periods.

When can shareholders exercise their right to convert?

Shareholders may exercise their conversion right starting from a set date until a specified deadline.

What are the dividend rates for Series 1 and Series 2 Shares?

Series 1 Shares have a fixed dividend rate, while Series 2 Shares have a quarterly floating dividend rate that may adjust over time.

What is an Automatic Conversion?

An Automatic Conversion happens if fewer than 1,000,000 Series 1 Shares remain outstanding, leading to a one-for-one conversion into Series 2 Shares.

How can investors obtain more details about their shares?

Investors can contact their brokers or Capital Power's investor relations team for further details on shares and company policies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Mouser Electronics Invites Engineers to Innovation Showcase

Updated Category News Views 56

Mouser Electronics planned to make waves at the Embedded World North America 2024, taking place from October 8 to 10. This inaugural event aimed to gather the crème de la crème of the embedded community under one roof, offering a fertile ground for innovation and knowledge exchange. Mouser's Showcase: What to Expect? With industry experts set to share insights through...

Continue Reading
Exploring the Growth Potential of the Exosome Research Market

Updated Category News Views 165

Exploring the Exosome Research Market Trends The global exosome research market is on an impressive trajectory, with projections estimating its value to reach around USD 961.41 million in the next decade. The growth is attributed to a staggering compound annual growth rate (CAGR) of approximately 17.47% during the period from 2025 to 2034. In 2024, the market was valued...

Continue Reading
Vivakor Engages in $3.5 Million Stock Offer for Growth

Updated Category News Views 145

Vivakor Engages in $3.5 Million Stock Offer for Growth Vivakor, Inc. (NASDAQ: VIVK), a company specializing in integrated energy infrastructure and environmental services, has recently announced a significant move in its financing strategy. This announcement involves a registered direct offering, through which the company anticipates raising approximately $3.5 million....

Continue Reading
BlackRock TCP Capital Corp. Gets Credit Ratings Boost

Updated Category News Views 115

In the gritty world of finance, ratings can make or break a company’s standing in the eyes of investors. Recently, BlackRock TCP Capital Corp. (NASDAQ: TCPC) snagged a much-coveted upgrade from Kroll Bond Rating Agency (KBRA), signaling robust operational health intertwined with strategic smarts. The new issuer and senior unsecured debt ratings of BBB- come laced with a...

Continue Reading
Investor Sentiment Shifts Amid Oil Price Concerns for ExxonMobil

Updated Category News Views 140

Falling Oil Prices Put Pressure on ExxonMobil ExxonMobil (NYSE: XOM) slipped 3.1% in a choppy trading session, giving back not only today’s gains but part of yesterday’s progress as well. The company’s share price often moves with crude, and this time that link is clear. What’s different now is that broader market forces are piling on, amplifying the slide and...

Continue Reading